|
|
|
Iqvia Holdings Inc (NYSE: IQV) |
|
|
|
| |
Iqvia Holdings Inc Outlook |
On February 6 2025 the Iqvia Holdings Inc provided following guidance
nnIQVIA Holdings Inc. Reports Q4 and Full-Year 2024 Financial Results; Reiterates 2025 Projectionsnn
Research Triangle Park, N.C. – February 6, 2025 – IQVIA Holdings Inc. (NYSE: IQV), a premier global provider of advanced clinical research services, commercial insights, and healthcare analytical tools in the life sciences sector, announced its financial outcomes for the fourth quarter and the complete year of 2024.
Ari Bousbib, the Chairman and CEO of IQVIA, expressed confidence in the company’s performance, stating, We are pleased to report strong results for the fourth quarter, marking a successful conclusion to 2024. He highlighted that revenue from Research and Development Solutions (RandDS) met company expectations, while new bookings surpassed projections, indicating robust demand for IQVIA's services.
In addition to reporting past financial performance, IQVIA has reaffirmed its guidance for the full year of 2025, although specific figures and details regarding the guidance were not included in the release. This reaffirmation underscores the company's commitment to maintaining momentum and responding effectively to the evolving needs of its clients in the healthcare and life sciences landscape.
The results reflect IQVIA’s resilience and adaptability in a dynamic market, affirming its position as a leader in providing crucial insights and services that enhance the quality and efficiency of healthcare outcomes worldwide.,
|
On February 14 2024 the Iqvia Holdings Inc provided following guidance
24. Adjusted EBITDA for the fourth quarter of 2023 was $694 million, representing a 3.4 percent increase on a reported basis and a 2.5 percent increase at constant currency compared to the same quarter in 2022.
For the full year 2023, IQVIA reported revenue of $15,162 million, a 6.1 percent increase on a reported basis and a 4.9 percent increase at constant currency compared to the previous year. Adjusted EBITDA for the full year was $2,908 million, a 6.6 percent increase on a reported basis and a 5.5 percent increase at constant currency compared to the previous year.
IQVIA has also issued guidance for the full year 2024. The company expects revenue to be in the range of $16,000 million to $16,500 million, representing a growth rate of 5.6 percent to 9 percent on a reported basis and 4.2 percent to 7.7 percent at constant currency. Adjusted EBITDA for 2024 is projected to be in the range of $3,100 million to $3,300 million, indicating a growth rate of 6.7 percent to 13.4 percent on a reported basis and 5.3 percent to 12 percent at constant currency.
Overall, IQVIA Holdings Inc. has reported positive financial results for the fourth quarter and full year 2023, with consistent growth in revenue and adjusted EBITDA. The company is optimistic about its future prospects and expects continued growth in revenue and adjusted EBITDA for the full year 2024.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
